Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Short Interest Update

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 492,300 shares, a growth of 11.7% from the December 31st total of 440,600 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 1,230.8 days.

Kyowa Kirin Price Performance

KYKOF remained flat at $14.80 on Monday. Kyowa Kirin has a 52 week low of $13.28 and a 52 week high of $22.21. The stock has a 50 day moving average of $15.33 and a two-hundred day moving average of $17.87.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.